236 related articles for article (PubMed ID: 14965246)
1. 5-HT7 receptors.
Thomas DR; Hagan JJ
Curr Drug Targets CNS Neurol Disord; 2004 Feb; 3(1):81-90. PubMed ID: 14965246
[TBL] [Abstract][Full Text] [Related]
2. 5-ht6 receptors.
Woolley ML; Marsden CA; Fone KC
Curr Drug Targets CNS Neurol Disord; 2004 Feb; 3(1):59-79. PubMed ID: 14965245
[TBL] [Abstract][Full Text] [Related]
3. 5-HT5 receptors.
Nelson DL
Curr Drug Targets CNS Neurol Disord; 2004 Feb; 3(1):53-8. PubMed ID: 14965244
[TBL] [Abstract][Full Text] [Related]
4. 5-HT1 receptors.
Lanfumey L; Hamon M
Curr Drug Targets CNS Neurol Disord; 2004 Feb; 3(1):1-10. PubMed ID: 14965240
[TBL] [Abstract][Full Text] [Related]
5. Serotonin receptors and therapeutics.
Launay JM; Callebert J; Bondoux D; Loric S; Maroteaux L
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):327-36. PubMed ID: 7522716
[TBL] [Abstract][Full Text] [Related]
6. 5-HT4 receptors.
Bockaert J; Claeysen S; Compan V; Dumuis A
Curr Drug Targets CNS Neurol Disord; 2004 Feb; 3(1):39-51. PubMed ID: 14965243
[TBL] [Abstract][Full Text] [Related]
7. 5-HT2 receptors.
Leysen JE
Curr Drug Targets CNS Neurol Disord; 2004 Feb; 3(1):11-26. PubMed ID: 14965241
[TBL] [Abstract][Full Text] [Related]
8. Ligands for the investigation of 5-HT autoreceptor function.
Roberts C; Price GW; Middlemiss DN
Brain Res Bull; 2001 Nov; 56(5):463-9. PubMed ID: 11750791
[TBL] [Abstract][Full Text] [Related]
9. Serotonergic modulation of retinal input to the mouse suprachiasmatic nucleus mediated by 5-HT1B and 5-HT7 receptors.
Smith BN; Sollars PJ; Dudek FE; Pickard GE
J Biol Rhythms; 2001 Feb; 16(1):25-38. PubMed ID: 11220775
[TBL] [Abstract][Full Text] [Related]
10. Functional, molecular and pharmacological advances in 5-HT7 receptor research.
Hedlund PB; Sutcliffe JG
Trends Pharmacol Sci; 2004 Sep; 25(9):481-6. PubMed ID: 15559250
[TBL] [Abstract][Full Text] [Related]
11. Serotonin and the mammalian circadian system: I. In vitro phase shifts by serotonergic agonists and antagonists.
Prosser RA; Dean RR; Edgar DM; Heller HC; Miller JD
J Biol Rhythms; 1993; 8(1):1-16. PubMed ID: 8490207
[TBL] [Abstract][Full Text] [Related]
12. 5-ht5A receptors as a therapeutic target.
Thomas DR
Pharmacol Ther; 2006 Sep; 111(3):707-14. PubMed ID: 16516972
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory effect of serotonin on the spontaneous discharge of suprachiasmatic neurons in hypothalamic slice is mediated by 5-HT(7) receptor.
Yu GD; Liu YL; Jiang XH; Guo SY; Zhang HQ; Yin QZ; Hisamitsu T
Brain Res Bull; 2001 Mar; 54(4):395-8. PubMed ID: 11306191
[TBL] [Abstract][Full Text] [Related]
14. Medicinal chemistry of 5-HT5A receptor ligands: a receptor subtype with unique therapeutical potential.
Volk B; Nagy BJ; Vas S; Kostyalik D; Simig G; Bagdy G
Curr Top Med Chem; 2010; 10(5):554-78. PubMed ID: 20166946
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of serotonin 5-HT
Thirumaran SL; Lepailleur A; Rochais C
Eur J Med Chem; 2019 Dec; 183():111705. PubMed ID: 31581003
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in 5-HT1B/1D receptor antagonists and agonists and their potential therapeutic applications.
Slassi A
Curr Top Med Chem; 2002 Jun; 2(6):559-74. PubMed ID: 12052194
[TBL] [Abstract][Full Text] [Related]
17. Pyrroloquinoxaline derivatives as high-affinity and selective 5-HT(3) receptor agonists: synthesis, further structure-activity relationships, and biological studies.
Campiani G; Morelli E; Gemma S; Nacci V; Butini S; Hamon M; Novellino E; Greco G; Cagnotto A; Goegan M; Cervo L; Dalla Valle F; Fracasso C; Caccia S; Mennini T
J Med Chem; 1999 Oct; 42(21):4362-79. PubMed ID: 10543880
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychotoxicity of abused drugs: effects of serotonin receptor ligands on methamphetamine- and cocaine-induced behavioral sensitization in mice.
Ago Y; Nakamura S; Baba A; Matsuda T
J Pharmacol Sci; 2008 Jan; 106(1):15-21. PubMed ID: 18198473
[TBL] [Abstract][Full Text] [Related]
19. Memories are made of this (perhaps): a review of serotonin 5-HT(6) receptor ligands and their biological functions.
Russell MG; Dias R
Curr Top Med Chem; 2002 Jun; 2(6):643-54. PubMed ID: 12052198
[TBL] [Abstract][Full Text] [Related]
20. 8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production.
Sprouse J; Reynolds L; Li X; Braselton J; Schmidt A
Neuropharmacology; 2004 Jan; 46(1):52-62. PubMed ID: 14654097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
